🇺🇸 FDA
Patent

US 11713324

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

granted A61PA61P1/00A61P1/04

Quick answer

US patent 11713324 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P13/02